{
event: "article_read",
name: `SoliMix Study Results Summary`,
author: ``,
tags: `Diabetes | Diabetes`,
publication_date: ``,
interaction_type: "content"
}
SoliMix Study Results Summary
Discover clinical outcomes with iGlarLixi versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial leading to advancing therapy in sub-optimally controlled basal insulin-treated Type-2 diabetes.
.jpg/jcr:content/image%20(20).jpg)
Related articles
MAT-BH-2300623/v1/November2023